VPS35 and Parkinson disease: Our findings indicate that the VPS35 D620N mutation inhibits neurogenesis in PD, likely through hub targets such as PI3K and AKT1, and the PI3K-Akt signaling pathway, providing mechanistic insights into its role in PD-associated neuronal degeneration.